I would have thought my opening post was blindly obvious. One of...

I would have thought my opening post was blindly obvious. One of the worlds largest insulin makers, can see a timeline on its very existence - in it current form anyway - it's not going to be because we chant prayers and ask diabetes to go away. It's going to be, because better treatments, including cell based therapies become increasingly available over the next few years.  If you look at the MSB pipeline, you'll see a strong focus in this area, with data expected over the next few months - hopefully, by this time next year - subject to trial results - we'll be into a USFDA fast-tracked PhIII - but, let's wait and see.

I've said all along - it's this application that has the potential to "stop traffic"!  I like very much how our executive team as flown it as much as possible below the radar.  Results talk being their creed.  BIG 2015 ahead.